siRNA nanocarriers based on methacrylic acid copolymers
Poly(ethylene glycol)- b-poly(propyl methacrylate- co-methacrylic acid) (PEG- b-P(PrMA- co-MAA) can be complexed with poly(amido amine) (PAMAM) dendrimers and nucleic acids to form pH-responsive nanosized core-shell type polyion complex micelles (PICMs). These PICMs have the ability to lose their sh...
Gespeichert in:
Veröffentlicht in: | Journal of controlled release 2011-05, Vol.152 (1), p.159-167 |
---|---|
Hauptverfasser: | , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 167 |
---|---|
container_issue | 1 |
container_start_page | 159 |
container_title | Journal of controlled release |
container_volume | 152 |
creator | Felber, Arnaud E. Castagner, Bastien Elsabahy, Mahmoud Deleavey, Glen F. Damha, Masad J. Leroux, Jean-Christophe |
description | Poly(ethylene glycol)-
b-poly(propyl methacrylate-
co-methacrylic acid) (PEG-
b-P(PrMA-
co-MAA) can be complexed with poly(amido amine) (PAMAM) dendrimers and nucleic acids to form pH-responsive nanosized core-shell type polyion complex micelles (PICMs). These PICMs have the ability to lose their shell and release the PAMAM/nucleic acid core under mildly acidic conditions such as those encountered in the endosomal compartment. In this work, pH-sensitive PICMs composed of PEG-
b-P(PrMA-
co-MAA), different PAMAMs, and siRNAs were prepared and characterized. These micelles had mean diameters ranging from 50 to 100
nm depending on the structure of the polycationic component. In order to trigger PICM uptake by receptor-mediated endocytosis, the micelles were decorated with an antibody fragment directed against the transferrin receptor (anti-CD71). The targeting ligand was stably conjugated to a semi-telechelic amino-PEG-
b-P(PrMA-
co-MAA)
via a maleimide/activated ester bifunctional linker, yielding up to 60%–80% functionalization of the maleimide groups. The cellular uptake of the micelles was assessed on human prostate cancer cells (PC-3)
via flow cytometry. Native PICMs and micelles bearing a non-specific antibody fragment were taken up to the same extent with a low efficiency, whereas anti-CD71 Fab′-decorated PICMs exhibited significantly higher uptake. The capacity of the targeted, siRNA-loaded, PICMs to downregulate the expression of the Bcl-2 anti-apoptotic oncoprotein was investigated using the appropriate unmodified or 2′-modified (2′F-RNA and 2′F-ANA) siRNA sequence. Bcl-2 mRNA and protein levels were greatly reduced when the cells were transfected with anti-CD71 decorated PICMs. Optimal silencing was achieved with the chemically modified siRNA. These data suggest that combining optimized siRNA chemistry with an effective delivery system can potentiate the activity of siRNA, thereby potentially reducing the total dose of carrier required to achieve a pharmacological effect.
Delivery of siRNA using ligand-decorated pH-responsive polyion complex micelles.
[Display omitted] |
doi_str_mv | 10.1016/j.jconrel.2010.12.012 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_871000749</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0168365910010266</els_id><sourcerecordid>871000749</sourcerecordid><originalsourceid>FETCH-LOGICAL-c451t-872120e545455ae9e08a65f57f1998e882eb5bb5905deee7139b4f7bda5e738e3</originalsourceid><addsrcrecordid>eNqF0c9r2zAUB3BRVto025-wzZfRXpzqpyWdSghtNwgtdMtZyPJzq2BbmeQM8t9XIVl729BBID56T-8rhD4TPCOYVNfr2dqFIUI3o3h_RmeY0BM0IUqykmstPqBJdqpkldDn6CKlNcZYMC7P0DklRAvJqgmSyT89zIvBDsHZGD3EVNQ2QVOEoehhfLEu7jrvCut8U7iwCd2uz-gjOm1tl-DTcZ-i1d3tr8X3cvl4_2MxX5aOCzKWSlJCMQiel7CgAStbiVbIlmitQCkKtahrobFoAEASpmveyrqxAiRTwKbo8lB3E8PvLaTR9D456Do7QNgmoyTJY0mus7z6p8ypcYKZljJTcaAuhpQitGYTfW_jLqO9q8zaHNM1-3QNoSanm-99ObbY1j00b7f-xpnBtyOwydmujXZwPr07zmjF85BT9PXgWhuMfY7ZrH7mTgJjooik-0o3BwE53D_5W0xyHgYHjY_gRtME_5_HvgKEpqJg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1014103977</pqid></control><display><type>article</type><title>siRNA nanocarriers based on methacrylic acid copolymers</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals Complete</source><creator>Felber, Arnaud E. ; Castagner, Bastien ; Elsabahy, Mahmoud ; Deleavey, Glen F. ; Damha, Masad J. ; Leroux, Jean-Christophe</creator><creatorcontrib>Felber, Arnaud E. ; Castagner, Bastien ; Elsabahy, Mahmoud ; Deleavey, Glen F. ; Damha, Masad J. ; Leroux, Jean-Christophe</creatorcontrib><description>Poly(ethylene glycol)-
b-poly(propyl methacrylate-
co-methacrylic acid) (PEG-
b-P(PrMA-
co-MAA) can be complexed with poly(amido amine) (PAMAM) dendrimers and nucleic acids to form pH-responsive nanosized core-shell type polyion complex micelles (PICMs). These PICMs have the ability to lose their shell and release the PAMAM/nucleic acid core under mildly acidic conditions such as those encountered in the endosomal compartment. In this work, pH-sensitive PICMs composed of PEG-
b-P(PrMA-
co-MAA), different PAMAMs, and siRNAs were prepared and characterized. These micelles had mean diameters ranging from 50 to 100
nm depending on the structure of the polycationic component. In order to trigger PICM uptake by receptor-mediated endocytosis, the micelles were decorated with an antibody fragment directed against the transferrin receptor (anti-CD71). The targeting ligand was stably conjugated to a semi-telechelic amino-PEG-
b-P(PrMA-
co-MAA)
via a maleimide/activated ester bifunctional linker, yielding up to 60%–80% functionalization of the maleimide groups. The cellular uptake of the micelles was assessed on human prostate cancer cells (PC-3)
via flow cytometry. Native PICMs and micelles bearing a non-specific antibody fragment were taken up to the same extent with a low efficiency, whereas anti-CD71 Fab′-decorated PICMs exhibited significantly higher uptake. The capacity of the targeted, siRNA-loaded, PICMs to downregulate the expression of the Bcl-2 anti-apoptotic oncoprotein was investigated using the appropriate unmodified or 2′-modified (2′F-RNA and 2′F-ANA) siRNA sequence. Bcl-2 mRNA and protein levels were greatly reduced when the cells were transfected with anti-CD71 decorated PICMs. Optimal silencing was achieved with the chemically modified siRNA. These data suggest that combining optimized siRNA chemistry with an effective delivery system can potentiate the activity of siRNA, thereby potentially reducing the total dose of carrier required to achieve a pharmacological effect.
Delivery of siRNA using ligand-decorated pH-responsive polyion complex micelles.
[Display omitted]</description><identifier>ISSN: 0168-3659</identifier><identifier>EISSN: 1873-4995</identifier><identifier>DOI: 10.1016/j.jconrel.2010.12.012</identifier><identifier>PMID: 21195736</identifier><identifier>CODEN: JCREEC</identifier><language>eng</language><publisher>Kidlington: Elsevier B.V</publisher><subject>amines ; Antibodies ; Bcl-2 ; Bcl-2 protein ; Biological and medical sciences ; Cell Line, Tumor ; Cell Survival - drug effects ; composite polymers ; Controlled release ; Copolymers ; Data processing ; Endocytosis ; Esters ; ethylene glycol ; Flow cytometry ; Gene Transfer Techniques ; General pharmacology ; Humans ; Male ; Medical sciences ; messenger RNA ; Methacrylic acid ; Methacrylic acid copolymers ; Micelles ; mRNA ; nanocarriers ; Nanoparticles - chemistry ; neoplasm cells ; nucleic acids ; oncogene proteins ; pH effects ; pH-sensitivity ; Pharmaceutical technology. Pharmaceutical industry ; Pharmacology. Drug treatments ; Polyethylene Glycols - chemistry ; Polyion complex micelles ; Polymethacrylic Acids - chemical synthesis ; Polymethacrylic Acids - chemistry ; Prostate cancer ; prostatic neoplasms ; RNA, Small Interfering - chemistry ; Shells ; siRNA ; small interfering RNA ; transferrin ; Transferrin receptors</subject><ispartof>Journal of controlled release, 2011-05, Vol.152 (1), p.159-167</ispartof><rights>2010 Elsevier B.V.</rights><rights>2015 INIST-CNRS</rights><rights>Copyright © 2010 Elsevier B.V. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c451t-872120e545455ae9e08a65f57f1998e882eb5bb5905deee7139b4f7bda5e738e3</citedby><cites>FETCH-LOGICAL-c451t-872120e545455ae9e08a65f57f1998e882eb5bb5905deee7139b4f7bda5e738e3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.jconrel.2010.12.012$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>309,310,314,780,784,789,790,3550,23930,23931,25140,27924,27925,45995</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=24326471$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/21195736$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Felber, Arnaud E.</creatorcontrib><creatorcontrib>Castagner, Bastien</creatorcontrib><creatorcontrib>Elsabahy, Mahmoud</creatorcontrib><creatorcontrib>Deleavey, Glen F.</creatorcontrib><creatorcontrib>Damha, Masad J.</creatorcontrib><creatorcontrib>Leroux, Jean-Christophe</creatorcontrib><title>siRNA nanocarriers based on methacrylic acid copolymers</title><title>Journal of controlled release</title><addtitle>J Control Release</addtitle><description>Poly(ethylene glycol)-
b-poly(propyl methacrylate-
co-methacrylic acid) (PEG-
b-P(PrMA-
co-MAA) can be complexed with poly(amido amine) (PAMAM) dendrimers and nucleic acids to form pH-responsive nanosized core-shell type polyion complex micelles (PICMs). These PICMs have the ability to lose their shell and release the PAMAM/nucleic acid core under mildly acidic conditions such as those encountered in the endosomal compartment. In this work, pH-sensitive PICMs composed of PEG-
b-P(PrMA-
co-MAA), different PAMAMs, and siRNAs were prepared and characterized. These micelles had mean diameters ranging from 50 to 100
nm depending on the structure of the polycationic component. In order to trigger PICM uptake by receptor-mediated endocytosis, the micelles were decorated with an antibody fragment directed against the transferrin receptor (anti-CD71). The targeting ligand was stably conjugated to a semi-telechelic amino-PEG-
b-P(PrMA-
co-MAA)
via a maleimide/activated ester bifunctional linker, yielding up to 60%–80% functionalization of the maleimide groups. The cellular uptake of the micelles was assessed on human prostate cancer cells (PC-3)
via flow cytometry. Native PICMs and micelles bearing a non-specific antibody fragment were taken up to the same extent with a low efficiency, whereas anti-CD71 Fab′-decorated PICMs exhibited significantly higher uptake. The capacity of the targeted, siRNA-loaded, PICMs to downregulate the expression of the Bcl-2 anti-apoptotic oncoprotein was investigated using the appropriate unmodified or 2′-modified (2′F-RNA and 2′F-ANA) siRNA sequence. Bcl-2 mRNA and protein levels were greatly reduced when the cells were transfected with anti-CD71 decorated PICMs. Optimal silencing was achieved with the chemically modified siRNA. These data suggest that combining optimized siRNA chemistry with an effective delivery system can potentiate the activity of siRNA, thereby potentially reducing the total dose of carrier required to achieve a pharmacological effect.
Delivery of siRNA using ligand-decorated pH-responsive polyion complex micelles.
[Display omitted]</description><subject>amines</subject><subject>Antibodies</subject><subject>Bcl-2</subject><subject>Bcl-2 protein</subject><subject>Biological and medical sciences</subject><subject>Cell Line, Tumor</subject><subject>Cell Survival - drug effects</subject><subject>composite polymers</subject><subject>Controlled release</subject><subject>Copolymers</subject><subject>Data processing</subject><subject>Endocytosis</subject><subject>Esters</subject><subject>ethylene glycol</subject><subject>Flow cytometry</subject><subject>Gene Transfer Techniques</subject><subject>General pharmacology</subject><subject>Humans</subject><subject>Male</subject><subject>Medical sciences</subject><subject>messenger RNA</subject><subject>Methacrylic acid</subject><subject>Methacrylic acid copolymers</subject><subject>Micelles</subject><subject>mRNA</subject><subject>nanocarriers</subject><subject>Nanoparticles - chemistry</subject><subject>neoplasm cells</subject><subject>nucleic acids</subject><subject>oncogene proteins</subject><subject>pH effects</subject><subject>pH-sensitivity</subject><subject>Pharmaceutical technology. Pharmaceutical industry</subject><subject>Pharmacology. Drug treatments</subject><subject>Polyethylene Glycols - chemistry</subject><subject>Polyion complex micelles</subject><subject>Polymethacrylic Acids - chemical synthesis</subject><subject>Polymethacrylic Acids - chemistry</subject><subject>Prostate cancer</subject><subject>prostatic neoplasms</subject><subject>RNA, Small Interfering - chemistry</subject><subject>Shells</subject><subject>siRNA</subject><subject>small interfering RNA</subject><subject>transferrin</subject><subject>Transferrin receptors</subject><issn>0168-3659</issn><issn>1873-4995</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2011</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqF0c9r2zAUB3BRVto025-wzZfRXpzqpyWdSghtNwgtdMtZyPJzq2BbmeQM8t9XIVl729BBID56T-8rhD4TPCOYVNfr2dqFIUI3o3h_RmeY0BM0IUqykmstPqBJdqpkldDn6CKlNcZYMC7P0DklRAvJqgmSyT89zIvBDsHZGD3EVNQ2QVOEoehhfLEu7jrvCut8U7iwCd2uz-gjOm1tl-DTcZ-i1d3tr8X3cvl4_2MxX5aOCzKWSlJCMQiel7CgAStbiVbIlmitQCkKtahrobFoAEASpmveyrqxAiRTwKbo8lB3E8PvLaTR9D456Do7QNgmoyTJY0mus7z6p8ypcYKZljJTcaAuhpQitGYTfW_jLqO9q8zaHNM1-3QNoSanm-99ObbY1j00b7f-xpnBtyOwydmujXZwPr07zmjF85BT9PXgWhuMfY7ZrH7mTgJjooik-0o3BwE53D_5W0xyHgYHjY_gRtME_5_HvgKEpqJg</recordid><startdate>20110530</startdate><enddate>20110530</enddate><creator>Felber, Arnaud E.</creator><creator>Castagner, Bastien</creator><creator>Elsabahy, Mahmoud</creator><creator>Deleavey, Glen F.</creator><creator>Damha, Masad J.</creator><creator>Leroux, Jean-Christophe</creator><general>Elsevier B.V</general><general>Elsevier</general><scope>FBQ</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QO</scope><scope>7TM</scope><scope>8FD</scope><scope>FR3</scope><scope>P64</scope><scope>7X8</scope></search><sort><creationdate>20110530</creationdate><title>siRNA nanocarriers based on methacrylic acid copolymers</title><author>Felber, Arnaud E. ; Castagner, Bastien ; Elsabahy, Mahmoud ; Deleavey, Glen F. ; Damha, Masad J. ; Leroux, Jean-Christophe</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c451t-872120e545455ae9e08a65f57f1998e882eb5bb5905deee7139b4f7bda5e738e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2011</creationdate><topic>amines</topic><topic>Antibodies</topic><topic>Bcl-2</topic><topic>Bcl-2 protein</topic><topic>Biological and medical sciences</topic><topic>Cell Line, Tumor</topic><topic>Cell Survival - drug effects</topic><topic>composite polymers</topic><topic>Controlled release</topic><topic>Copolymers</topic><topic>Data processing</topic><topic>Endocytosis</topic><topic>Esters</topic><topic>ethylene glycol</topic><topic>Flow cytometry</topic><topic>Gene Transfer Techniques</topic><topic>General pharmacology</topic><topic>Humans</topic><topic>Male</topic><topic>Medical sciences</topic><topic>messenger RNA</topic><topic>Methacrylic acid</topic><topic>Methacrylic acid copolymers</topic><topic>Micelles</topic><topic>mRNA</topic><topic>nanocarriers</topic><topic>Nanoparticles - chemistry</topic><topic>neoplasm cells</topic><topic>nucleic acids</topic><topic>oncogene proteins</topic><topic>pH effects</topic><topic>pH-sensitivity</topic><topic>Pharmaceutical technology. Pharmaceutical industry</topic><topic>Pharmacology. Drug treatments</topic><topic>Polyethylene Glycols - chemistry</topic><topic>Polyion complex micelles</topic><topic>Polymethacrylic Acids - chemical synthesis</topic><topic>Polymethacrylic Acids - chemistry</topic><topic>Prostate cancer</topic><topic>prostatic neoplasms</topic><topic>RNA, Small Interfering - chemistry</topic><topic>Shells</topic><topic>siRNA</topic><topic>small interfering RNA</topic><topic>transferrin</topic><topic>Transferrin receptors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Felber, Arnaud E.</creatorcontrib><creatorcontrib>Castagner, Bastien</creatorcontrib><creatorcontrib>Elsabahy, Mahmoud</creatorcontrib><creatorcontrib>Deleavey, Glen F.</creatorcontrib><creatorcontrib>Damha, Masad J.</creatorcontrib><creatorcontrib>Leroux, Jean-Christophe</creatorcontrib><collection>AGRIS</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Biotechnology Research Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of controlled release</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Felber, Arnaud E.</au><au>Castagner, Bastien</au><au>Elsabahy, Mahmoud</au><au>Deleavey, Glen F.</au><au>Damha, Masad J.</au><au>Leroux, Jean-Christophe</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>siRNA nanocarriers based on methacrylic acid copolymers</atitle><jtitle>Journal of controlled release</jtitle><addtitle>J Control Release</addtitle><date>2011-05-30</date><risdate>2011</risdate><volume>152</volume><issue>1</issue><spage>159</spage><epage>167</epage><pages>159-167</pages><issn>0168-3659</issn><eissn>1873-4995</eissn><coden>JCREEC</coden><abstract>Poly(ethylene glycol)-
b-poly(propyl methacrylate-
co-methacrylic acid) (PEG-
b-P(PrMA-
co-MAA) can be complexed with poly(amido amine) (PAMAM) dendrimers and nucleic acids to form pH-responsive nanosized core-shell type polyion complex micelles (PICMs). These PICMs have the ability to lose their shell and release the PAMAM/nucleic acid core under mildly acidic conditions such as those encountered in the endosomal compartment. In this work, pH-sensitive PICMs composed of PEG-
b-P(PrMA-
co-MAA), different PAMAMs, and siRNAs were prepared and characterized. These micelles had mean diameters ranging from 50 to 100
nm depending on the structure of the polycationic component. In order to trigger PICM uptake by receptor-mediated endocytosis, the micelles were decorated with an antibody fragment directed against the transferrin receptor (anti-CD71). The targeting ligand was stably conjugated to a semi-telechelic amino-PEG-
b-P(PrMA-
co-MAA)
via a maleimide/activated ester bifunctional linker, yielding up to 60%–80% functionalization of the maleimide groups. The cellular uptake of the micelles was assessed on human prostate cancer cells (PC-3)
via flow cytometry. Native PICMs and micelles bearing a non-specific antibody fragment were taken up to the same extent with a low efficiency, whereas anti-CD71 Fab′-decorated PICMs exhibited significantly higher uptake. The capacity of the targeted, siRNA-loaded, PICMs to downregulate the expression of the Bcl-2 anti-apoptotic oncoprotein was investigated using the appropriate unmodified or 2′-modified (2′F-RNA and 2′F-ANA) siRNA sequence. Bcl-2 mRNA and protein levels were greatly reduced when the cells were transfected with anti-CD71 decorated PICMs. Optimal silencing was achieved with the chemically modified siRNA. These data suggest that combining optimized siRNA chemistry with an effective delivery system can potentiate the activity of siRNA, thereby potentially reducing the total dose of carrier required to achieve a pharmacological effect.
Delivery of siRNA using ligand-decorated pH-responsive polyion complex micelles.
[Display omitted]</abstract><cop>Kidlington</cop><pub>Elsevier B.V</pub><pmid>21195736</pmid><doi>10.1016/j.jconrel.2010.12.012</doi><tpages>9</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0168-3659 |
ispartof | Journal of controlled release, 2011-05, Vol.152 (1), p.159-167 |
issn | 0168-3659 1873-4995 |
language | eng |
recordid | cdi_proquest_miscellaneous_871000749 |
source | MEDLINE; Elsevier ScienceDirect Journals Complete |
subjects | amines Antibodies Bcl-2 Bcl-2 protein Biological and medical sciences Cell Line, Tumor Cell Survival - drug effects composite polymers Controlled release Copolymers Data processing Endocytosis Esters ethylene glycol Flow cytometry Gene Transfer Techniques General pharmacology Humans Male Medical sciences messenger RNA Methacrylic acid Methacrylic acid copolymers Micelles mRNA nanocarriers Nanoparticles - chemistry neoplasm cells nucleic acids oncogene proteins pH effects pH-sensitivity Pharmaceutical technology. Pharmaceutical industry Pharmacology. Drug treatments Polyethylene Glycols - chemistry Polyion complex micelles Polymethacrylic Acids - chemical synthesis Polymethacrylic Acids - chemistry Prostate cancer prostatic neoplasms RNA, Small Interfering - chemistry Shells siRNA small interfering RNA transferrin Transferrin receptors |
title | siRNA nanocarriers based on methacrylic acid copolymers |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-27T07%3A33%3A32IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=siRNA%20nanocarriers%20based%20on%20methacrylic%20acid%20copolymers&rft.jtitle=Journal%20of%20controlled%20release&rft.au=Felber,%20Arnaud%20E.&rft.date=2011-05-30&rft.volume=152&rft.issue=1&rft.spage=159&rft.epage=167&rft.pages=159-167&rft.issn=0168-3659&rft.eissn=1873-4995&rft.coden=JCREEC&rft_id=info:doi/10.1016/j.jconrel.2010.12.012&rft_dat=%3Cproquest_cross%3E871000749%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1014103977&rft_id=info:pmid/21195736&rft_els_id=S0168365910010266&rfr_iscdi=true |